Related references
Note: Only part of the references are listed.CXCL13/CXCR5 signaling axis in cancer
Muzammal Hussain et al.
LIFE SCIENCES (2019)
Serum CXCL13 reflects local B-cell mediated inflammatory demyelinating peripheral neuropathy
Young Hee Kim et al.
SCIENTIFIC REPORTS (2019)
Serum-based differentiation between multiple sclerosis and amyotrophic lateral sclerosis by Random Forest classification of FTIR spectra
Youssef El Khoury et al.
ANALYST (2019)
RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue
Antonio Vallarola et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis
Jason R. Thonhoff et al.
CURRENT OPINION IN NEUROLOGY (2018)
Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice
Giovanni Nardo et al.
MOLECULAR NEURODEGENERATION (2018)
Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model
Jingjing Zhang et al.
TRANSLATIONAL NEURODEGENERATION (2018)
Pharmacokinetics of an intracerebroventricularly administered antibody in rats
Yuki Noguchi et al.
MABS (2017)
Amyotrophic lateral sclerosis
Orla Hardiman et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
CXCL12/SDF-1 from perisynaptic Schwann cells promotes regeneration of injured motor axonterminals
Samuele Negro et al.
EMBO MOLECULAR MEDICINE (2017)
New Insights on the Mechanisms of Disease Course Variability in ALS from Mutant SOD1 Mouse Models
Giovanni Nardo et al.
BRAIN PATHOLOGY (2016)
CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5
Bao-Chun Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Immune response in peripheral axons delays disease progression in SOD1G93A mice
Giovanni Nardo et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis
SungWon Song et al.
NATURE MEDICINE (2016)
CXCL13 antibody for the treatment of autoimmune disorders
Ekaterina Klimatcheva et al.
BMC IMMUNOLOGY (2015)
CCL2 Mediates Neuron-Macrophage Interactions to Drive Proregenerative Macrophage Activation Following Preconditioning Injury
Min Jung Kwon et al.
JOURNAL OF NEUROSCIENCE (2015)
Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis
Marianna Marino et al.
NEUROBIOLOGY OF AGING (2015)
Investigations on CXCL13 in Anti-N-Methyl-D-Aspartate Receptor Encephalitis A Potential Biomarker of Treatment Response
Frank Leypoldt et al.
JAMA NEUROLOGY (2015)
Type-I Interferons Suppress Microglial Production of the Lymphoid Chemokine, CXCL13
Nilufer Esen et al.
GLIA (2014)
Repetitive hypoxic preconditioning induces an immunosuppressed B cell phenotype during endogenous protection from stroke
Nancy L. Monson et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Specific Induction of Akt3 in Spinal Cord Motor Neurons is Neuroprotective in a Mouse Model of Familial Amyotrophic Lateral Sclerosis
Marco Peviani et al.
MOLECULAR NEUROBIOLOGY (2014)
Stages of pTDP-43 Pathology in Amyotrophic Lateral Sclerosis
Johannes Brettschneider et al.
ANNALS OF NEUROLOGY (2013)
Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis
Giovanni Nardo et al.
BRAIN (2013)
CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions
Enrique Alvarez et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis
Martin R. Turner et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
Markus C. Kowarik et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Neuroprotective Effects of Toll-Like Receptor 4 Antagonism in Spinal Cord Cultures and in a Mouse Model of Motor Neuron Degeneration
Massimiliano De Paola et al.
MOLECULAR MEDICINE (2012)
The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trials
Ettore Beghi et al.
AMYOTROPHIC LATERAL SCLEROSIS (2011)
Clinical diagnosis and management of amyotrophic lateral sclerosis
Orla Hardiman et al.
NATURE REVIEWS NEUROLOGY (2011)
Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation?
M. Rentzos et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Guidelines for preclinical animal research in ALS/MND: A consensus meeting
Albert C. Ludolph et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients
Milan Fiala et al.
JOURNAL OF NEUROINFLAMMATION (2010)
CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients
Lars Fischer et al.
CLINICAL CANCER RESEARCH (2009)
Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis
J. Kuhle et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Possible role of glial cells in the onset and progression of Lyme neuroborreliosis
Geeta Ramesh et al.
JOURNAL OF NEUROINFLAMMATION (2009)
The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis
Tobias A. Rupprecht et al.
JOURNAL OF NEUROINFLAMMATION (2009)
Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes
Shulamit Naor et al.
JOURNAL OF NEUROLOGY (2009)
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
F. Sellebjerg et al.
NEUROLOGY (2009)
Immune Proteins in Brain Development and Synaptic Plasticity
Lisa M. Boulanger
NEURON (2009)
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Koji Yamanaka et al.
NATURE NEUROSCIENCE (2008)
Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
Rebecca Banerjee et al.
PLOS ONE (2008)
CD4+T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS
David R. Beers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS
Isaac M. Chiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Chemokines and chemokine receptors in neurological disease: Raise, retain, or reduce?
Carine Savarin-Vuaillat et al.
NEUROTHERAPEUTICS (2007)
Neuronal chemokines: Versatile messengers in central nervous system cell interaction
A. H. de Haas et al.
MOLECULAR NEUROBIOLOGY (2007)
ALS:: A disease of motor neurons and their nonneuronal neighbors
Sverine Boillee et al.
NEURON (2006)
CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis
Ludmila V. Bagaeva et al.
JOURNAL OF IMMUNOLOGY (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
M Krumbholz et al.
BRAIN (2006)
The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis
K Narayan et al.
ANNALS OF NEUROLOGY (2005)
Complexity of Astrocyte-Motor Neuron Interactions in Amyotrophic Lateral Sclerosis
Mariana Pehar et al.
NEURODEGENERATIVE DISEASES (2005)
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis
R Magliozzi et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5
CDC Allen et al.
NATURE IMMUNOLOGY (2004)
Immune signalling in neural development, synaptic plasticity and disease
LM Boulanger et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity
RS Klein et al.
TRENDS IN IMMUNOLOGY (2004)
Role of the α-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system
F Lazarini et al.
GLIA (2003)
Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma
JR Smith et al.
BLOOD (2003)
A chemokine-driven positive feedback loop organizes lymphoid follicles
KM Ansel et al.
NATURE (2000)
Share Paper
